Global Immunohematology and Infectious Disease NAT Screening Market, 2019-2023: Supplier Shares, and Competitive Analysis of Major Players and Emerging Market Entrants
This new report from LeadingMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Contains 50 pages
Contains 50 pages
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/Gen-Probe
Immucor
Ortho-Clinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher/Life Technologies
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/Gen-Probe
Immucor
Ortho-Clinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher/Life Technologies
More Publications
Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Assays, Strategic Profiles of Leading Suppliers
US$ 3,850.00
June 2019
280 pages
2019 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares by Country, Screening Assays, and Strategic Profiles of Leading Suppliers
US$ 3,850.00
February 2019
280 pages
2019 Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Supplier Shares by Country, Screening Assays, and Companies Developing New Technologies and Products
US$ 3,850.00
February 2019
197 pages
